Chemical Structure (Depo Medrol 01)
Depo-medrol Injection, Suspension
Product Images NDC 0009-3073
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Depo-medrol (NDC 0009-3073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Depo Medrol 02)
Principal Display Panel (40 mg/mL Vial Label)
This is a prescription medication called Depo-Medrol (methylprednisolone acetate injectable suspension, USP) intended for intrasynovial and soft tissue injections only. It is not for IV use. The dosage and usage instructions can be found in the accompanying prescribing information. Shake well before use. Manufactured by Pharmacia & Upjohn Co, a division of Pfizer Inc, located in New York, NY. This is a single-dose vial containing 1 mL of the medication.*
Principal Display Panel (40 mg/mL Vial Carton)
This is a description of a medication called Depo-Medrol® which is an injectable suspension containing methylprednisolone acetate at a concentration of 40 mg/mL. It is intended for intramuscular, intrasynovial, and soft tissue injection only. The medication should be stored at controlled room temperature and shaken before use. The text provides information on the dosage and usage of the medication, as well as its composition including ingredients like polyethylene glycol and myristyl-gamma picolinium chloride. Additional details are also provided about the formulation adjustments made including the addition of sodium chloride.*
Principal Display Panel (80 mg/mL Vial Label)
This text provides information about a medication called Depo-Medrol. It is indicated for intrasynovial and soft tissue injections only and should not be used intravenously. The dosage and usage instructions can be found in the accompanying prescribing information. The medication comes in a 1 mL single-dose vial containing methylPREDNISolone acetate injectable suspension at a concentration of 80 mg/mL. It is distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, based in New York, NY. The product is marked Rx only.*
Principal Display Panel (80 mg/mL Vial Carton)
This text provides information regarding a medication called Depo-Medrol, which is an injectable suspension of methylprednisolone acetate at a concentration of 80 mg/mL. It is indicated for intramuscular, intrasynovial, and soft tissue infections only. The text also includes details about dosage, storage conditions (between 20° to 25°C), and instructions to shake before use. Additionally, it mentions the chemical composition of the medication, including methylprednisolone acetate and other compounds.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
